MX2015010191A - Metodos para tratar infecciones microbianas, incluyendo mastitis. - Google Patents

Metodos para tratar infecciones microbianas, incluyendo mastitis.

Info

Publication number
MX2015010191A
MX2015010191A MX2015010191A MX2015010191A MX2015010191A MX 2015010191 A MX2015010191 A MX 2015010191A MX 2015010191 A MX2015010191 A MX 2015010191A MX 2015010191 A MX2015010191 A MX 2015010191A MX 2015010191 A MX2015010191 A MX 2015010191A
Authority
MX
Mexico
Prior art keywords
methods
microbial infections
treating microbial
including mastitis
subject
Prior art date
Application number
MX2015010191A
Other languages
English (en)
Inventor
Stephen Page
Sanjay Garg
Original Assignee
Luoda Pharma Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013900411A external-priority patent/AU2013900411A0/en
Application filed by Luoda Pharma Pty Ltd filed Critical Luoda Pharma Pty Ltd
Publication of MX2015010191A publication Critical patent/MX2015010191A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención incluye métodos y composiciones para el tratamiento de la mastitis en un sujeto. El método incluye el paso de administración, mediante liberación intramamaria, una cantidad terapéuticamente efectiva de un poliéter ionóforo, o una sal terapéuticamente aceptable del mismo, a la glándula mamaria del sujeto.
MX2015010191A 2013-02-08 2014-02-10 Metodos para tratar infecciones microbianas, incluyendo mastitis. MX2015010191A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2013900411A AU2013900411A0 (en) 2013-02-08 Methods Of Treating Microbial Infections, Including Mastitis
PCT/AU2014/000102 WO2014121343A1 (en) 2013-02-08 2014-02-10 Methods of treating microbial infections, including mastitis

Publications (1)

Publication Number Publication Date
MX2015010191A true MX2015010191A (es) 2016-08-03

Family

ID=51299091

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015010191A MX2015010191A (es) 2013-02-08 2014-02-10 Metodos para tratar infecciones microbianas, incluyendo mastitis.

Country Status (11)

Country Link
US (1) US11491105B2 (es)
EP (1) EP2953624B1 (es)
JP (1) JP6779619B2 (es)
KR (1) KR20150115837A (es)
CN (2) CN113559264A (es)
AU (1) AU2014214548B2 (es)
CA (1) CA2900373C (es)
MX (1) MX2015010191A (es)
NZ (1) NZ710757A (es)
RU (1) RU2662300C2 (es)
WO (1) WO2014121343A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104586855A (zh) * 2014-12-29 2015-05-06 天津市中升挑战生物科技有限公司 一种复方利福昔明子宫注入剂及其制备方法与应用
CN104774223A (zh) * 2015-03-26 2015-07-15 宁夏泰瑞制药股份有限公司 一种利用泰乐菌素碱生产泰地罗新的方法
CN107216353B (zh) * 2016-03-21 2020-05-19 山东诚创医药技术开发有限公司 一种头孢洛林酯咪唑盐的精制方法
CN107536864B (zh) * 2016-06-23 2020-12-25 西安乐民反刍动物研究所 用于反刍动物常见外科疾病的预防治疗喷剂及制备方法
WO2018019031A1 (en) * 2016-07-27 2018-02-01 Institut Pasteur Of Shanghai, Chinese Academy Of Sciences A pharmaceutical composition comprising an ionophore and a beta-lactam antibiotic and use thereof
CN106727294A (zh) * 2016-12-23 2017-05-31 常州润诺生物科技有限公司 一种硫酸依替米星的口服制剂及其制备方法与应用
CN108671000B (zh) * 2018-07-04 2021-05-28 佛山市南海东方澳龙制药有限公司 一种复方药剂及其用途
WO2020194298A1 (en) * 2019-03-25 2020-10-01 The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) Method of treating bovine mastitis
CN110368394B (zh) * 2019-06-25 2022-10-11 华中农业大学 一种阿维拉霉素在猪产气荚膜梭菌抑制药物中的应用
CN110376366B (zh) * 2019-07-19 2020-10-02 吉林大学 一种烟酸通过gpr109a受体应用于治疗奶牛乳腺炎的实验方法
CN111514142B (zh) * 2020-05-29 2021-04-06 江苏亚虹医药科技股份有限公司 含硝羟喹啉前药的药物组合物及其制备方法和应用
IL303943A (en) * 2020-12-24 2023-08-01 Intervet Int Bv Methods for treating mastitis using the antimicrobial orthosomycin compound
CN112870166B (zh) * 2021-01-20 2022-04-08 中山大学 一种核丛青霉素固体分散体、制备方法及应用
CN113040094B (zh) * 2021-03-18 2022-06-21 中国农业大学 一种牛支原体性小鼠乳腺炎模型的构建方法及其应用
RU2762088C1 (ru) * 2021-05-05 2021-12-15 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский ветеринарный институт патологии, фармакологии и терапии" (ФГБНУ "ВНИВИПФиТ") Способ лечения мастита у коров
KR20240015754A (ko) * 2022-07-26 2024-02-06 주식회사 인트론바이오테크놀로지 젖소유방염 치료용 항균단백질 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2171966B1 (es) * 1972-02-17 1975-03-14 Pierrefitte Auby Sa
AU4633893A (en) * 1992-06-17 1994-01-04 University Of Massachusetts Medical Center Liposomal formulations for administering to cancer patients
EP0934075B1 (en) * 1996-06-20 2002-04-03 Novartis AG Micrococcin atibiotic for the prevention and treatment of mastitis
CA2316767A1 (en) * 1999-09-01 2001-03-01 Bridget Mccarthy Cole Somatostatin antagonists and agonists that act at the sst subtype 2 receptor
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
JP2006520779A (ja) * 2003-03-20 2006-09-14 ファルマシア コーポレイション 抗炎症薬の分散性処方物
WO2005072644A1 (en) * 2004-02-02 2005-08-11 Bimeda Research & Development Limited Method and device for treating a teat canal of an animal
EP2138171A1 (en) * 2008-06-18 2009-12-30 Istituto Superiore Di Sanita' Veterinarian compositions containing terpinen-4-ol for the treatment and prevention of mastitis
BRPI1002601E2 (pt) * 2010-06-01 2020-06-30 Embrapa Pesquisa Agropecuaria composição nanoestruturada de uso veterinário para administração de fármacos
RU2013155085A (ru) * 2011-05-12 2015-06-20 Интервет Интернэшнл Б.В. Лечение мастита
WO2014001353A1 (en) * 2012-06-29 2014-01-03 Bayer Animalhealth Gmbh Pharmaceutical compositions and treatment of mastitis

Also Published As

Publication number Publication date
RU2662300C2 (ru) 2018-07-25
AU2014214548B2 (en) 2018-03-29
NZ710757A (en) 2020-04-24
KR20150115837A (ko) 2015-10-14
CA2900373C (en) 2021-02-16
JP2016507533A (ja) 2016-03-10
CN105492005A (zh) 2016-04-13
EP2953624A1 (en) 2015-12-16
RU2015132211A (ru) 2017-03-16
WO2014121343A1 (en) 2014-08-14
EP2953624A4 (en) 2016-07-13
JP6779619B2 (ja) 2020-11-04
US20150366797A1 (en) 2015-12-24
CA2900373A1 (en) 2014-08-14
WO2014121343A9 (en) 2016-09-09
EP2953624B1 (en) 2019-08-21
CN113559264A (zh) 2021-10-29
AU2014214548A1 (en) 2015-08-20
US11491105B2 (en) 2022-11-08

Similar Documents

Publication Publication Date Title
MX2015010191A (es) Metodos para tratar infecciones microbianas, incluyendo mastitis.
MX2015010190A (es) Metodos de tratamiento topico para infecciones microbianas.
EP4282479A3 (en) Use of pridopidine to treat depression or anxiety
PH12016500207A1 (en) Anti-infective compounds
NZ713621A (en) Compounds and methods of treating infections
MY177740A (en) Treatment of cataplexy
PH12015501588B1 (en) Compounds and methods for treating bacterial infections
MX2015009045A (es) Composiciones y metodos para tratar el dolor severo.
MX363678B (es) Terapia de combinación que comprende oxazolidinona-quinolonas para usarse en el tratamiento de infecciones bacterianas.
EA032271B9 (ru) Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний
WO2014160281A3 (en) Method of enhancing delivery of therapeutic compounds to the eye
NZ702415A (en) Methods for treating neutropenia using retinoid agonists
NZ730092A (en) Use of cysteamine in treating infections caused by yeasts/moulds
MX363631B (es) Composiciones y metodos para tratar infecciones bacterianas.
WO2014152437A3 (en) Methods of use for an antimicrobial peptide
PH12018500358A1 (en) Compounds for use in an antibacterial applications
MX2022014763A (es) Composiciones de grapiprant y metodos para usar las mismas.
IN2013MU03216A (es)
EA201690446A1 (ru) Лечение множественной миеломы
MY198753A (en) Treatment of androgen deprivation therapy associated symptoms
EA201690445A1 (ru) Лечение рака
MX2018004881A (es) Aditivo para tratamiento posterior interno de composiciones aglutinantes minerales.
MX2016001912A (es) Metodos para tratar infecciones oticas luego de la colocacion de un tubo de timpanostomia.
MX365285B (es) Complejo lubricante para la boca.
IN2013MU03428A (es)

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: LUODA PHARMA LIMITED

FG Grant or registration